AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner(TM)...

AbbeyMoor Medical Receives FDA Approval for Design Improvements to The
Spanner(TM) Prostatic Stent

PARKERS PRAIRIE, Minn., July 6 /PRNewswire/ -- AbbeyMoor Medical Inc., a
developer and manufacturer of medical devices for the management and treatment
of prostatic obstruction, announced today that it has received PMA approval
from the US Food and Drug Administration (FDA) for design changes to their
flagship product, The Spanner(TM) Prostatic Stent.

"These changes are aimed at further improving patient comfort over the current
highly accepted levels," said Darren Cook, director of marketing with the
company. "Our goal is to hear an even greater percentage of our patient's
state that they are not aware of the device's presence." According to Mark
Whalen, VP of product development with the company, "The approved changes to
the device result in a significant increase in flexibility over the current
Spanner design with no impact to the ease of delivery and removal of the
device."

The Spanner is a temporary prostatic stent designed to aid men who are
experiencing difficulty in urination due to prostatic obstruction. Device
placement can be performed in a physician office and does not require
cystoscopy or anesthesia for placement. The Spanner is an alternative to
indwelling catheterization, intermittent catheterization, or the use of a
suprapubic tube in some patients.

About AbbeyMoor Medical
AbbeyMoor Medical is a privately held company that develops innovative medical
devices focused on the management and treatment of male voiding dysfunction.
The company's initial focus is on the development and commercialization of The
Spanner.

For more information, please visit www.thespanner.com

SOURCE AbbeyMoor Medical, Inc.

Darren Cook, Director of Marketing of AbbeyMoor Medical Inc., +1-218-338-6700